Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

TikTok cracks down on users posting about popular weight loss drugs

As the demand for GLP-1 based drugs grows, content about the new class of weight loss drugs on TikTok has fueled the flames of its

July 19, 2023

Clinicians Star in Off-Broadway Musical About Antimicrobial Resistance

It’s not every day that working scientists and healthcare professionals sing alongside seasoned actors in a show, let alone in a musical about a pressing

September 7, 2024

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update – Biotech Investments

Issuer: CureVac / Key word(s): Quarter Results 15.08.2024 / 13:06 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Announces Financial

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.